We show that RBMS1 may play an important role in the regulation of adipocyte differentiation and metabolism and may offer a novel therapeutic opportunity for metabolic disorders such as obesity and type 2 diabetes. Here, RBMS1 is linked to type 2 diabetes mellitus.